Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 7/20 | 0.41 |
| ▸ | CCNB1 | P14635 | 7/20 | 0.41 |
| ▸ | VCAM1 | P19320 | 2/20 | 0.39 |
| ▸ | CCNA2 | P20248 | 6/20 | 0.39 |
| ▸ | CDK2 | P24941 | 6/20 | 0.39 |
| ▸ | CCNA1 | P78396 | 6/20 | 0.39 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.36 |
| ▸ | MGMT | P16455 | 2/20 | 0.36 |
| ▸ | LTB4R | Q15722 | 2/20 | 0.33 |
| ▸ | CTSS | P25774 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8903452 | 1.00 | CDK1 (0.41) | CDK1CCNB1VCAM1CCNA2CDK2 | |
| SCHEMBL8903387 | 0.96 | CDK1 (0.39) | CDK1CCNB1VCAM1CCNA2CDK2 | |
| SCHEMBL8901655 | 0.88 | CDK1 (0.55) | CDK1CCNB1CCNA2CDK2CCNA1 | |
| SCHEMBL8902911 | 0.88 | CDK1 (0.55) | CDK1CCNB1CCNA2CDK2CCNA1 | |
| SCHEMBL8903318 | 0.86 | CDK1 (0.53) | CDK1CCNB1CCNA2CDK2CCNA1 | |
| SCHEMBL8902364 | 0.84 | CDK1 (0.52) | CDK1CCNB1CCNA2CDK2CCNA1 | |
| SCHEMBL8903180 | 0.84 | VCAM1 (0.39) | VCAM1LTB4RPTGS2 | |
| SCHEMBL8903449 | 0.84 | VCAM1 (0.39) | VCAM1LTB4RPTGS2 | |
| SCHEMBL8902502 | 0.81 | CDK1 (0.55) | CDK1CCNB1CCNA2CDK2CCNA1 | |
| SCHEMBL8901822 | 0.80 | PTGS2 (0.46) | ADORA3CTSSCTSKPTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5602140-A | CAUSED BY LEUKOCYTES | JAPAN ENERGY CORPORATION (JP) | 1997-02-11 | — | — | US | disclosed |
| EP-0675124-A2 | Purine derivatives and suppressants for inflammatory diseases | JAPAN ENERGY CORPORATION (JP) | 1995-10-04 | — | — | EP | disclosed |